Sputum interleukin-6, tumor necrosis factor-α and Salivary cortisol as new biomarkers of depression in lung cancer patients

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 47, Issue , 2013, Pages 69-76

  Du, Yi jie ^a   Zhang, Hong ying ^a   Li, Bei ^a   Wu, Xiao ^a   Lv, Yu bao ^a   Jin, Hua liang ^a   Cao, Yu xue ^a   Sun, Jing ^a   Luo, Qing li ^a   Gong, Wei yi ^a   Liu, Bao jun ^a   Wu, Jin feng ^a   Shi, Shen xun ^a   Dong, Jing cheng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Biomarkers; Cortisol; Cytokines; Depression; Diurnal rhythm; Lung cancer

Indexed keywords

HYDROCORTISONE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CANCER PATIENT; CIRCADIAN RHYTHM; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HAMILTON SCALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; RECEIVER OPERATING CHARACTERISTIC; SALIVA LEVEL; SENSITIVITY AND SPECIFICITY; SPUTUM;

ANOVA; AREA UNDER THE DIURNAL VARIATION CURVES; AUC; BIOMARKERS; CI; CONFIDENCE INTERVAL; CORTISOL; CYTOKINES; DEPRESSION; DIURNAL RHYTHM; FEV1; FORCED EXPIRATORY VOLUME IN 1S; FORCED VITAL CAPACITY; FVC; HADS; HAM-D; HAMILTON DEPRESSION RATING SCALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HPA; HYPOTHALAMIC-PITUITARY-ADRENAL; IL-6; INTERLEUKIN-6; KARNOFSKY PERFORMANCE STATUS; KPS; LUNG CANCER; ONE WAY ANALYSIS OF VARIANCE; PEAK EXPIRATORY FLOW; PEF; QOL; QUALITY OF LIFE; RADIOIMMUNOASSAY; RECEIVER OPERATING CHARACTERISTIC; RELATIVE DIURNAL VARIATION; RIA; ROC; SD; STANDARD DEVIATION; TNF-Α; TUMOR NECROSIS FACTOR-Α; VAR;

ANALYSIS OF VARIANCE; DEPRESSION; FEMALE; HUMANS; HYDROCORTISONE; INTERLEUKIN-6; LUNG NEOPLASMS; MALE; MIDDLE AGED; PSYCHOMETRICS; ROC CURVE; SALIVA; SPUTUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883675112     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.08.004     Document Type: Article

References (41)

1. Aardal-Eriksson E., Eriksson T.E., Holm A.C., Lundin T. Salivary cortisol and serum prolactin in relation to stress rating scales in a group of rescue workers. Biol Psychiatry 1999, 46(6):850-855.
2. Alesci S., Martinez P.E., Kelkar S., Ilias I., Ronsaville D.S., Listwak S.J., et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 2005, 90(5):2522-2530.
3. Bacci E., Cianchetti S., Carnevali S., Bartoli M.L., Dente F.L., Di Franco A., et al. Induced sputum is a reproducible method to assess airway inflammation in asthma. Mediators Inflamm 2002, 11(5):293-298.
4. Bollinger T., Bollinger A., Naujoks J., Lange T., Solbach W. The influence of regulatory T cells and diurnal hormone rhythms on T helper cell activity. Immunology 2010, 131(4):488-500.
5. Bower J.E., Ganz P.A., Dickerson S.S., Petersen L., Aziz N., Fahey J.L. Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 2005, 30(1):92-100.
6. Buske-Kirschbaum A., Geiben A., Hollig H., Morschhauser E., Hellhammer D. Altered responsiveness of the hypothalamus-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis. J Clin Endocrinol Metab 2002, 87(9):4245-4251.
7. Castelli L., Binaschi L., Caldera P., Mussa A., Torta R. Fast screening of depression in cancer patients: the effectiveness of the HADS. Eur J Cancer Care (Engl) 2011, 20(4):528-533.
8. Du Y.J., Li B., Zhang H.Y., Cao Y.X., Duan X.H., Gong W.Y., et al. Airway inflammation and hypothalamic-pituitary-adrenal axis activity in asthmatic adults with depression. J Asthma 2013, 50(3):274-281.
9. Elenkov I.J., Webster E.L., Torpy D.J., Chrousos G.P. Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Ann N Y Acad Sci 1999, 876:1-11. [discussion 11-13].
10. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967, 6(4):278-296.
11. Hamilton M. The role of rating scales in psychiatry. Psychol Med 1976, 6(3):347-349.
12. Hellhammer D.H., Wust S., Kudielka B.M. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology 2009, 34(2):163-171.
13. Heuser I., Deuschle M., Weber B., Stalla G.K., Holsboer F. Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone. Psychoneuroendocrinology 2000, 25(5):513-518.
14. Hopwood P., Stephens R.J. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 2000, 18(4):893-903.
15. Jehn C.F., Kuehnhardt D., Bartholomae A., Pfeiffer S., Krebs M., Regierer A.C., et al. Biomarkers of depression in cancer patients. Cancer 2006, 107(11):2723-2729.
16. Jehn C.F., Kuhnhardt D., Bartholomae A., Pfeiffer S., Schmid P., Possinger K., et al. Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer. Integr Cancer Ther 2010, 9(3):270-275.
17. Kim S.Y., Kim J.M., Kim S.W., Shin I.S., Park M.H., Yoon J.H., et al. Associations between plasma cytokines and depressive mood in patients with breast cancer. Int J Psychiatry Med 2012, 43(1):1-17.
18. Knorr U., Vinberg M., Kessing L.V., Wetterslev J. Salivary cortisol in depressed patients versus control persons: a systematic review and meta-analysis. Psychoneuroendocrinology 2010, 35(9):1275-1286.
19. Lindley S.E., Carlson E.B., Benoit M. Basal and dexamethasone suppressed salivary cortisol concentrations in a community sample of patients with posttraumatic stress disorder. Biol Psychiatry 2004, 55(9):940-945.
20. Lutgendorf S.K., Weinrib A.Z., Penedo F., Russell D., DeGeest K., Costanzo E.S., et al. Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. J Clin Oncol 2008, 26(29):4820-4827.
21. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 1995, 34(4):301-309.
22. Musselman D.L., Miller A.H., Porter M.R., Manatunga A., Gao F., Penna S., et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001, 158(8):1252-1257.
23. Nelson H.S., Stricker W., Casale T.B., Raff H., Fourre J.A., Aron D.C., et al. A comparison of methods for assessing hypothalamic-pituitary-adrenal (HPA) axis activity in asthma patients treated with inhaled corticosteroids. J Clin Pharmacol 2002, 42(3):319-326.
24. Nikitina O.V., Chainikova I.N., Skachkova M.A., Barsukova S.V. Features of immunity in tobacco smoking among adolescents. Gig Sanit 2012, (3):59-61.
25. Park S.W., Jangm H.K., An M.H., Min J.W., Jang A.S., Lee J.H., et al. Interleukin-13 and interleukin-5 in induced sputum of eosinophilic bronchitis: comparison with asthma. Chest 2005, 128(4):1921-1927.
26. Petrovsky N., McNair P., Harrison L.C. Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine 1998, 10(4):307-312.
27. Pin I., Gibson P.G., Kolendowicz R., Girgis-Gabardo A., Denburg J.A., Hargreave F.E., et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992, 47(1):25-29.
28. Pirl W.F., Temel J.S., Billings A., Dahlin C., Jackson V., Prigerson H.G., et al. Depression after diagnosis of advanced non-small cell lung cancer and survival: a pilot study. Psychosomatics 2008, 49(3):218-224.
29. Posener J.A., DeBattista C., Williams G.H., Chmura Kraemer H., Kalehzan B.M., Schatzberg A.F. 24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. Arch Gen Psychiatry 2000, 57(8):755-760.
30. Raison C.L., Miller A.H. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 2003, 54(3):283-294.
31. Rovina N., Hillas G., Dima E., Vlastos F., Loukides S., Veldekis D., et al. VEGF and IL-18 in induced sputum of lung cancer patients. Cytokine 2011, 54(3):277-281.
32. Schiepers O.J., Wichers M.C., Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29(2):201-217.
33. Skogar O., Fall P.A., Hallgren G., Lokk J., Bringer B., Carlsson M., et al. Diurnal salivary cortisol concentrations in Parkinson's disease: increased total secretion and morning cortisol concentrations. Int J Gen Med 2011, 4:561-569.
34. Soygur H., Palaoglu O., Akarsu E.S., Cankurtaran E.S., Ozalp E., Turhan L., et al. Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31(6):1242-1247.
35. Tagay S., Herpertz S., Langkafel M., Erim Y., Bockisch A., Senf W., et al. Health-related quality of life, depression and anxiety in thyroid cancer patients. Qual Life Res 2006, 15(4):695-703.
36. Tetikkurt C., Ozdemir I., Tetikkurt S., Yilmaz N., Ertan T., Bayar N. Anxiety and depression in COPD patients and correlation with sputum and BAL cytology. Multidiscip Respir Med 2011, 6(4):226-231.
37. Tornhage C.J. Salivary cortisol for assessment of hypothalamic-pituitary-adrenal axis function. Neuroimmunomodulation 2009, 16(5):284-289.
38. van Rensen E.L., Stirling R.G., Scheerens J., Staples K., Sterk P.J., Barnes P.J., et al. Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma. Thorax 2001, 56(12):935-940.
39. Vgontzas A.N., Zoumakis M., Papanicolaou D.A., Bixler E.O., Prolo P., Lin H.M., et al. Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism 2002, 51(7):887-892.
40. Vgontzas A.N., Zoumakis M., Bixler E.O., Lin H.M., Prolo P., Vela-Bueno A., et al. Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J Clin Endocrinol Metab 2003, 88(5):2087-2095.
41. Walker M.S., Zona D.M., Fisher E.B. Depressive symptoms after lung cancer surgery: their relation to coping style and social support. Psychooncology 2006, 15(8):684-693.